BRIEF published on 03/27/2026 at 09:44, 5 months 16 days ago Grünenthal annonce de solides résultats financiers pour 2025 Résultats Financiers Acquisitions Stratégiques Croissance Des Revenus Efficacité Opérationnelle Pipeline D'innovation
BRIEF published on 03/27/2026 at 09:44, 5 months 16 days ago Grünenthal Reports Strong Financial Results for 2025 Financial Results Revenue Growth Operational Efficiency Strategic Acquisitions Innovation Pipeline
PRESS RELEASE published on 03/27/2026 at 09:39, 5 months 16 days ago Grünenthal achieves outstanding financial results in 2025, powered by strategic growth, integration and diversification Grünenthal achieves outstanding 2025 financial results with €1.8 billion revenue and €500 million adjusted EBITDA, driven by growth, integration, and diversification Financial Results Adjusted EBITDA Revenue Strategic Growth Grünenthal
BRIEF published on 11/14/2025 at 15:35, 9 months 27 days ago Grünenthal augmente son émission obligataire de 175 millions d'euros Résultats Financiers Pharmaceutique Grünenthal Extension De Caution Émission De Titres De Créance
BRIEF published on 11/14/2025 at 15:35, 9 months 27 days ago Grünenthal Expands Bond Offering by €175 Million Financial Results Pharmaceutical Debt Issuance Grünenthal Bond Extension
PRESS RELEASE published on 11/14/2025 at 15:30, 9 months 27 days ago Grünenthal announces pricing of bond extension Grünenthal extends Senior Secured Notes by €175 million to a total of €675 million with 4.625% interest rate and maturity in 2031 Pharmaceutical Company Senior Secured Notes Grünenthal Debt Issue Bond Extension
BRIEF published on 03/27/2025 at 09:36, 1 year 5 months ago Grünenthal annonce de solides résultats financiers pour 2024 Résultats Financiers Croissance Stratégique Expansion Du Marché Américain Grünenthal 2024 Acquisition De Valinor
BRIEF published on 03/27/2025 at 09:36, 1 year 5 months ago Grünenthal Reports Strong 2024 Financial Results Financial Results Strategic Growth US Market Expansion Grünenthal 2024 Valinor Acquisition
PRESS RELEASE published on 03/27/2025 at 09:31, 1 year 5 months ago Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US Grünenthal reports exceptional 2024 financial results driven by strategic growth and Valinor acquisition in the US Financial Results 2024 Strategic Growth Grünenthal Valinor Acquisition
BRIEF published on 12/06/2024 at 13:22, 1 year 9 months ago Grünenthal émet avec succès une obligation de 500 millions d'euros Stratégie Financière Emission D'obligations 500 Millions D'euros Grünenthal Profil De Maturité
Published on 09/12/2026 at 02:35, 10 hours 49 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 24 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 19 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 15 hours 59 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 24 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 5 hours 54 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 9 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 14 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 39 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 9 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 17 hours ago Availability of the 2026 Interim Financial Report
